These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 20190203)
1. Assessment and management of fatigue in neuromuscular disease. Lou JS; Weiss MD; Carter GT Am J Hosp Palliat Care; 2010 Mar; 27(2):145-57. PubMed ID: 20190203 [TBL] [Abstract][Full Text] [Related]
2. Fatigue: an overview. Rosenthal TC; Majeroni BA; Pretorius R; Malik K Am Fam Physician; 2008 Nov; 78(10):1173-9. PubMed ID: 19035066 [TBL] [Abstract][Full Text] [Related]
3. Techniques in assessing fatigue in neuromuscular diseases. Lou JS Phys Med Rehabil Clin N Am; 2012 Feb; 23(1):11-22, ix. PubMed ID: 22239870 [TBL] [Abstract][Full Text] [Related]
4. Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study. Lou JS; Dimitrova DM; Park BS; Johnson SC; Eaton R; Arnold G; Nutt JG Clin Neuropharmacol; 2009; 32(6):305-10. PubMed ID: 19620846 [TBL] [Abstract][Full Text] [Related]
5. Modafinil for the treatment of pain-associated fatigue: review and case report. Fishbain DA; Cutler RB; Lewis J; Cole B; Rosomoff HL; Steele-Rosomoff R J Pain Palliat Care Pharmacother; 2004; 18(2):39-47. PubMed ID: 15257974 [TBL] [Abstract][Full Text] [Related]
6. The role of exercise in neuromuscular disease. Kilmer DD Phys Med Rehabil Clin N Am; 1998 Feb; 9(1):115-25, vi. PubMed ID: 9894136 [TBL] [Abstract][Full Text] [Related]
7. Fatigue and neuromuscular diseases. Féasson L; Camdessanché JP; El Mandhi L; Calmels P; Millet GY Ann Readapt Med Phys; 2006 Jul; 49(6):289-300, 375-84. PubMed ID: 16780988 [TBL] [Abstract][Full Text] [Related]
8. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis. Jones DE; Newton JL Aliment Pharmacol Ther; 2007 Feb; 25(4):471-6. PubMed ID: 17270003 [TBL] [Abstract][Full Text] [Related]
12. Treatment of cancer-related fatigue: an update. Escalante CP Support Care Cancer; 2003 Feb; 11(2):79-83. PubMed ID: 12560935 [TBL] [Abstract][Full Text] [Related]
13. Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series. Carter GT; Han JJ; Mayadev A; Weiss MD Am J Hosp Palliat Care; 2006; 23(5):412-6. PubMed ID: 17060310 [TBL] [Abstract][Full Text] [Related]
14. The development of an evidence-based physical self-management rehabilitation programme for cancer survivors. van Weert E; Hoekstra-Weebers JE; May AM; Korstjens I; Ros WJ; van der Schans CP Patient Educ Couns; 2008 May; 71(2):169-90. PubMed ID: 18255249 [TBL] [Abstract][Full Text] [Related]
15. Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants. Lam JY; Freeman MK; Cates ME Ann Pharmacother; 2007 Jun; 41(6):1005-12. PubMed ID: 17519297 [TBL] [Abstract][Full Text] [Related]
16. Modafinil treatment for fatigue associated with fibromyalgia. Schwartz TL; Rayancha S; Rashid A; Chlebowksi S; Chilton M; Morell M J Clin Rheumatol; 2007 Feb; 13(1):52. PubMed ID: 17278955 [No Abstract] [Full Text] [Related]
17. Modafinil for the treatment of fatigue in lung cancer: a pilot study. Spathis A; Dhillan R; Booden D; Forbes K; Vrotsou K; Fife K Palliat Med; 2009 Jun; 23(4):325-31. PubMed ID: 19270033 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of modafinil in the treatment of cancer-related fatigue. Cooper MR; Bird HM; Steinberg M Ann Pharmacother; 2009 Apr; 43(4):721-5. PubMed ID: 19318599 [TBL] [Abstract][Full Text] [Related]
19. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. Zifko UA; Rupp M; Schwarz S; Zipko HT; Maida EM J Neurol; 2002 Aug; 249(8):983-7. PubMed ID: 12195441 [TBL] [Abstract][Full Text] [Related]